Benzinga | Aug 16, 2021 06:51AM EDT

Protalix BioTherapeutics Q2 EPS $(0.25) Down From $(0.13) YoY

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.25) per share. This is a 92.31 percent decrease over losses of $(0.13) per share from the same period last year.